New hope for kids with rare cancers: Three-Drug combo under study
Disease control
Ongoing
This study tests a combination of three drugs—tazemetostat, nivolumab, and ipilimumab—for children with rare tumors that lack certain proteins (INI1 or SMARCA4). The goal is to find safe doses and see if the drugs shrink tumors. About 49 children with specific cancers like atypic…
Phase: PHASE1, PHASE2 • Sponsor: Susan Chi, MD • Aim: Disease control
Last updated May 13, 2026 16:00 UTC